Blog

Angela Lamarca: We MUST validate innovate biomarkers in clinical trials

Photo from Angela Lamarca/X

Jul 4, 2024, 12:15

Angela Lamarca: We MUST validate innovate biomarkers in clinical trials

Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on X:

“Last session of the day on Precision Medicine in European Network for the Study of Cholangiocarcinoma (ENS-CCA), Precision-BTC-Network joint meeting in Krakow.

surgical candidates
neoadjuvant
chemoresistance?
markers for IO
new markers- circRNAs

We MUST validate innovate biomarkers in clinical trials.”

Source: Angela Lamarca/X

Angela Lamarca biomarkers cancer Chemoresistance cholangiocarcinoma circRNAs clinical trials ENS-CCA European Network for the Study of Cholangiocarcinoma HPB Oncologist immunotherapy Jimenez Diaz Foundation neoadjuvant therapy NET Oncologist OncoDaily Oncology Precision Medicine Precision-BTC-Network

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage